- Home
- DCTH vs BACQ Comparison
DCTH vs BACQ Comparison
Compare DCTH & BACQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- BACQ
- Stock Information
- Founded
- DCTH 1988
- BACQ 2024
- Country
- DCTH United States
- BACQ United States
- Employees
- DCTH N/A
- BACQ N/A
- Industry
- DCTH Medical/Dental Instruments
- BACQ
- Sector
- DCTH Health Care
- BACQ
- Exchange
- DCTH Nasdaq
- BACQ NYSE
- Market Cap
- DCTH 398.2M
- BACQ 333.2M
- IPO Year
- DCTH N/A
- BACQ 2024
- Fundamental
- Price
- DCTH $14.31
- BACQ $9.89
- Analyst Decision
- DCTH Strong Buy
- BACQ
- Analyst Count
- DCTH 4
- BACQ 0
- Target Price
- DCTH $22.25
- BACQ N/A
- AVG Volume (30 Days)
- DCTH 411.6K
- BACQ 2.3K
- Earning Date
- DCTH 11-08-2024
- BACQ 01-01-0001
- Dividend Yield
- DCTH N/A
- BACQ N/A
- EPS Growth
- DCTH N/A
- BACQ N/A
- EPS
- DCTH N/A
- BACQ N/A
- Revenue
- DCTH $22,644,000.00
- BACQ N/A
- Revenue This Year
- DCTH $1,605.13
- BACQ N/A
- Revenue Next Year
- DCTH $111.67
- BACQ N/A
- P/E Ratio
- DCTH N/A
- BACQ N/A
- Revenue Growth
- DCTH 945.91
- BACQ N/A
- 52 Week Low
- DCTH $3.70
- BACQ N/A
- 52 Week High
- DCTH $14.47
- BACQ N/A
- Technical
- Relative Strength Index (RSI)
- DCTH 70.27
- BACQ N/A
- Support Level
- DCTH $12.14
- BACQ N/A
- Resistance Level
- DCTH $12.98
- BACQ N/A
- Average True Range (ATR)
- DCTH 0.77
- BACQ 0.00
- MACD
- DCTH 0.16
- BACQ 0.00
- Stochastic Oscillator
- DCTH 95.12
- BACQ 0.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About BACQ BLEICHROEDER ACQUISITION CORP. I
Bleichroeder Acquisition Corp I is a blank check company.